...
【24h】

Prognostic factors in well-differentiated thyroid carcinoma.

机译:高分化甲状腺癌的预后因素。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To test the prognostic significance of standard clinicopathologic factors in patients with well-differentiated thyroid carcinoma (WDTC). STUDY DESIGN: A retrospective chart review of the thyroid cancer database at Mount Sinai Hospital (Toronto, Canada 1963-2000) was carried out. METHODS: All patients consecutively treated for WDTC with a follow-up period of at least 5 years were eligible for inclusion. Relevant patient, tumor, treatment, and outcome data were collected. The main outcome measures were recurrence rate, actuarial overall, and disease-specific survival at 20 years. RESULTS: Three hundred and thirty-three patients (F 275, M 58) with a median age of 39.7 (range 9-82.9) years were eligible for inclusion in this study (median follow-up 10.4 years, range 5-34.4 years, minimum 5 years). The recurrence rate was 15.6% (52 /333). The overall and disease-specific survival at 10 years was 97.5% and 98.5%, respectively. Likewise, the overall and disease-specific survival at 20 years was 88.4% and 93.3%, respectively. Clinicopathologic factors significant on multivariate regression for the development of disease recurrence included family history of WDTC, advanced stage, and total thyroidectomy (all P < .05). Similarly, advanced stage on presentation was associated with a worse disease-specific survival on multivariate regression (all P < .05). There was a trend for age 60 or greater to predict disease-specific survival (P = .09). CONCLUSIONS: WDTC is associated with a significant recurrence rate but good disease-specific survival. The most important prognostic factors are family history of WDTC, extent of surgical treatment (i.e., total thyroidectomy), and advanced initial stage of disease, with a trend for age 60 years and older.
机译:目的:检验标准临床病理因素对高分化甲状腺癌(WDTC)患者的预后意义。研究设计:对西奈山医院(加拿大多伦多1963-2000年)的甲状腺癌数据库进行了回顾性图表审查。方法:所有连续接受WDTC治疗且随访期至少为5年的患者均符合纳入条件。收集相关的患者,肿瘤,治疗和结果数据。主要结果指标是复发率,总体精算值和20年特定疾病生存率。结果:333名患者(F 275,M 58)的中位年龄为39.7岁(范围9-82.9)岁,有资格被纳入本研究(中位随访期10.4年,范围5-34.4岁,至少5年)。复发率为15.6%(52/333)。 10年总生存率和疾病特异性生存率分别为97.5%和98.5%。同样,20年的总生存率和疾病特异性生存率分别为88.4%和93.3%。对于疾病发展的多因素回归显着影响的临床病理因素包括WDTC家族史,晚期和全甲状腺切除术(所有P <.05)。同样,呈报的晚期与多因素回归的疾病特异性生存率差相关(所有P <.05)。 60岁或更高年龄有预测疾病特异性存活的趋势(P = .09)。结论:WDTC与显着的复发率相关,但具有良好的疾病特异性生存率。最重要的预后因素是WDTC的家族病史,手术治疗的程度(即全甲状腺切除术)和疾病的早期初期阶段,其趋势是60岁以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号